Looking Back: Real-World Data on CAR-T and Bispecifics for RRMM | Natalia Neparidze, MD | #ASH24

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr. Natalia Neparidze talks Real World Data on CAR-T Therapy and Bispecific T-Cell Engagers for Relapsed or Refractory Myeloma Patients.

Link to ASH playlist: https://healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b

ASH Abstract: Real-World Treatment Patterns and Outcomes of Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (BiTE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) at the Yale Cancer Center Network (YCCN)
#ASH24 #myeloma #mmsm

Follow HealthTree: https://linktr.ee/HealthTreeUniversity
Category
Oncology
Be the first to comment

Up Next